Mahal Jeetinder Singh has filed 17 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 500000 shares of Jasper Therapeutics, Inc. ($JSPR) on February 06, 2026.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2026 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | CEO and President | A | Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 16,635,784 | 9999.99% | 3.01% |
| Jan. 2, 2026 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 16,635,784 | 9999.99% | 0.54% |
| June 4, 2025 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 90000 | $0.00 | 90,000.0000 | 15,022,122 | 9999.99% | 0.60% |
| Feb. 13, 2025 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 14,584,870 | 9999.99% | 0.34% |
| Dec. 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 13,772.0000 | 15,000,516 | 6.99% | 0.01% |
| Dec. 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $22.11 | 25,009.0000 | 15,000,516 | 3.47% | 0.01% |
| Dec. 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 15,000,516 | 3.60% | 0.01% |
| Sept. 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 14,672.0000 | 14,986,367 | 6.53% | 0.01% |
| Sept. 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 14,986,367 | 3.60% | 0.01% |
| Sept. 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $21.23 | 25,009.0000 | 14,986,367 | 3.47% | 0.01% |
| June 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 15,572.0000 | 13,334,900 | 6.13% | 0.01% |
| June 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $24.16 | 25,009.0000 | 13,334,900 | 3.47% | 0.01% |
| June 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 13,334,900 | 3.60% | 0.01% |
| March 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Stock Option (right to buy) | 900 | $0.00 | 16,472.0000 | 10,439,034 | 5.78% | 0.01% |
| March 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | M | Voting Common Stock | 900 | $7.10 | 25,909.0000 | 10,439,034 | 3.60% | 0.01% |
| March 12, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | S | Voting Common Stock | 900 | $26.44 | 25,009.0000 | 10,439,034 | 3.47% | 0.01% |
| Feb. 15, 2024 | Jasper Therapeutics, Inc. | $JSPR | Mahal Jeetinder Singh | Chief Operating Officer | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 10,439,034 | 9999.99% | 0.38% |